Clinical Trials (PDQ®) - National Cancer Institute

Page Options

Clinical Trial Questions?

Get Help:

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

Motivational Program for Smokers Enrolled in a Methadone Maintenance Program

Basic Trial Information
Trial Description
     Summary
     Further Trial Information
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
No phase specified Prevention Closed 18 to 75 NCI, Other CDR0000452798
RIH-0076-98, NCT00278226

Trial Description

Summary

RATIONALE: Stop-smoking programs may help patients stop smoking and prevent cancer from forming.

PURPOSE: This clinical trial is studying how well a motivational program works in helping smokers enrolled in a methadone maintenance program quit smoking.

Further Study Information

OBJECTIVES:

Determine the efficacy of a brief motivational intervention on smoking cessation in smokers enrolled in a methadone maintenance program.

OUTLINE: Patients are assigned to 1 of 2 groups.

Group 1: Patients undergo assessment at baseline and at 1, 3, and 6 months.

Group 2: Patients receive a brief motivational intervention at the time of their baseline assessment and undergo assessment as in group 1.

All patients will be offered a 2- to 3-month supply of nicotine patches.

PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.

Eligibility Criteria

DISEASE CHARACTERISTICS:

Must be currently enrolled in a methadone maintenance program

Smokes at least 10 cigarettes a day

PATIENT CHARACTERISTICS:

Not pregnant

No concurrent medical condition that precludes the use of nicotine patches

PRIOR CONCURRENT THERAPY:

No concurrent use of other nicotine replacement therapy

Trial Contact Information

Trial Lead Organizations/Sponsors

Rhode Island Hospital Comprehensive Cancer Center

National Cancer Institute

Michael Stein, MD

Study Chair

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00278226
Information obtained from ClinicalTrials.gov on February 01, 2010

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.